The vacuolar H + -ATPase (V-ATPase) is regulated by reversible disassembly into autoinhibited V1-ATPase and Vo proton channel sectors, a process that is poorly understood on the molecular level. 
Introduction
The vacuolar H + -ATPase (V-ATPase, V1Vo-ATPase) is an ATP dependent proton pump found on the endomembrane system of all eukaryotic organisms. This multisubunit nano-motor functions in acidifying subcellular compartments, and in certain specialized tissues, the extracellular environment. Acidification by the V-ATPase is required for vital cellular processes such as pH and ion homeostasis, protein trafficking, autophagy, endocytosis, mTOR and Notch signaling as well as bone remodeling, urine acidification, hormone secretion and neurotransmitter release (1) . While complete loss of V-ATPase function is embryonic lethal in mammals, aberrant activity has been associated with widespread human diseases such as renal tubular acidosis (2) , osteoporosis (3), neurodegeneration (4), diabetes (5) , male infertility (6) , and cancer (7), thereby establishing the V-ATPase as a potential drug target (8, 9) .
However, because of its essential and ubiquitous nature, global non-selective inhibition of V-ATPase is not a viable option. Instead, there is a need for targeted modulation of the enzyme's activity, a goal that requires a detailed understanding of V-ATPase's catalytic and regulatory mechanisms.
V-ATPase is a large (~ 1 MDa) membrane protein complex that can be divided into a cytosolic V1-ATPase and a membrane integral Vo proton channel. In yeast, V1 and Vo are made of A3B3(C) DE3FG3H and ac8c'c"def, respectively (10) . ATP hydrolysis takes place at three out of six A-B interfaces of the catalytic A3B3 hexamer. Located within the central cavity of the hexamer is subunit D, which together with F, provides the functional link between V1 and Vo. Vo is constituted by subunit a that can be divided into cytosolic N-terminal and membrane-integral C-terminal domains (aNT and aCT), the c, c' and c'' subunits ('proteolipids') that form a ring (c-ring), and subunit d. V1 and Vo are held together by three peripheral stalks, composed of heterodimers of subunits E and G (EG1-3) that connect the top of V1 to subunits C, H and aNT (Fig. 1A) . V-ATPase is a rotary motor enzyme and employs a catalytic mechanism that is shared with the F-, A-and A-/V-type ATPases (11) . In V-ATPase, ATP hydrolysis driven rotation of the central rotor (DFd and the c-ring) is coupled to proton translocation at the interface of aCT and the cring. During catalysis, the three peripheral stalks, in conjunction with C, H and aNT, resist the rotary torque, thus keeping the A3B3 hexamer static against aCT for efficient energy coupling.
Role of subunit H in V-ATPase assembly
Unlike the related F-and A-ATPases, eukaryotic V-ATPase is regulated in vivo by a unique mechanism referred to as "reversible disassembly", characterized by the detachment of V1 from Vo and the release of subunit C into the cytosol (12) (13) (14) (Fig. 1B) . The disassembly of V1 from Vo, is accompanied by their "autoinhibition", wherein free Vo no longer translocates protons (15, 16) , and free V1 no longer hydrolyzes MgATP (17, 18) . V-ATPase reversible disassembly was first described in yeast and insect, but is now emerging as an important regulatory mechanism in higher animals including human (19) (20) (21) , and while there is some understanding of reversible disassembly at the cellular level (22) , little is known about its molecular mechanism. Reversible disassembly requires the concerted breakage and reforming of subunit-subunit interactions, most of which involve the peripheral stator subunits E,G,H,C, and aNT. Using purified subunits and their domains, we found that while the head domain of C (Chead) and the N-terminal domain of H (HNT) bind EG with nanomolar affinity, C's foot domain (Cfoot), EG and H, all bind aNT weakly (23, 24) . It was therefore suggested that the V1-Vo interface is constituted by multiple low-affinity interactions that result in high-avidity binding. While the high-avidity allows for robust rotary catalysis, the low-affinity of the individual interactions permits efficient regulation of the enzyme by reversible disassembly (23, 25) .
Recent structural studies revealed that in assembled V1Vo, the C-terminal domain of H (HCT) is bound to aNT (26) , an interaction required for coupling V1's ATPase to Vo's proton pumping activities (Fig. 1A) (27) . Upon disassembly of V1 from Vo, HCT undergoes a 150º rotation to wedge its inhibitory loop between the B subunit of an open catalytic site and the central stalk (DF) on V1 ( Supplementary   Fig. S1A-D, red spheres) . At the same time, aNT moves from its peripheral position near Cfoot and EG that it occupies in V1Vo (28) (Fig. 1A) , towards a central position in autoinhibited Vo to bind subunit d (Supplementary Fig. S1E-G) (16, (29) (30) (31) . Moreover, a comparison of the cryoEM models of the three rotary states of holo V-ATPase (28) with the structures of autoinhibited V1 (32) and Vo (29, 31) showed that while V1 is halted in state 2, free Vo adopted state 3 (10) (Supplementary Fig. S1 ). From this observation, we hypothesized that the state mismatch together with the large conformational changes of HCT and aNT that accompany enzyme dissociation explain why V1 does not readily bind free Vo under Role of subunit H in V-ATPase assembly physiological conditions in vitro (10, 33) , a safety-mechanism that likely evolved to prevent spontaneous reassembly in vivo when the disassembled state is required.
We recently introduced biolayer interferometry (BLI) of purified V-ATPase in biotinylated and endogenous vacuolar lipid containing nanodiscs to study enzyme dissociation (34) . Here, we have expanded on this approach to study the interaction of V1 and Vo. Vo sector was reconstituted into vacuolar lipid containing nanodiscs (VoND) and immobilized on BLI sensors to screen V1 mutants for their ability to bind Vo. We show that V1 in which wild type H is replaced with chimeric H composed of yeast HNT and human HCT (Hchim; V1Hchim) (32) was able to bind VoND to form a structurally and functionally coupled V-ATPase (V1HchimVoND). Characterization of V1HchimVoND revealed biophysical and enzymatic properties similar to the previously characterized wild type V1VoND (34) . However, V1HchimVoND was more resistant to ATP hydrolysis induced disassembly compared to wild type, highlighting the importance of HCT's conformational switch in driving V-ATPase disassembly. The data also show that native vacuolar lipids are required for the generation of coupled MgATPase activity in reconstituted V1HchimVoND. From the in vitro data presented here, we propose a molecular model for the reassembly of holo V-ATPase from autoinhibited V1 and Vo in vivo.
Results

Purification and characterization of native lipid nanodisc reconstituted Vo (VoND) and V1 mutants
Vo was extracted from yeast vacuoles using the 'reconstitution before purification' strategy as described for V1Vo (34) (Fig. 1C(i-iii) ). The resultant VoND complex consisted of Vo embedded in endogenous vacuolar lipid containing nanodiscs encircled by biotinylated MSP (Fig. 1C(iii) ). The purified complex was monodisperse and contained all Vo subunits plus MSP based on gel filtration and SDS-PAGE (Fig.   1D,E) . Examination of purified VoND using negative stain electron microscopy showed single particles of VoND with the typical size and appearance as described previously (30) (Fig. 1F) .
Four different V1 mutants were tested for their ability to bind VoND and form coupled holo VATPase ( Fig. 2A) : wild type V1, V1 purified from a yeast strain deleted for subunit H (V1ΔH), V1ΔH (32, 35) (Fig. 2B,C , blue trace and bar). Although MgATPase activity is measured in an ATP regenerating system, the activity of V1ΔH decreases over time as MgADP gets trapped in a closed catalytic site, leading to the MgADP inhibited state (18, 24) . V1Hwt, which distinguishes itself from wild type V1 by having only ~0.4 instead of 1.3 mol/mol ADP in catalytic sites (32) , exhibits an initial MgATPase activity of ~ 4.95 ± 0.55 U/mg before becoming MgADP inhibited (Fig. 2B,C light green) .
Reconstitution of V1ΔH with Hchim resulted in V1Hchim (Fig. 2D-F) , which showed an initial MgATPase activity of 8.2 ± 0.4 U/mg that, as for the other V1 mutants, declined over time due to MgADP inhibition (Fig. 2B,C pink) .
V1Hchim and C subunit associate with VoND to form coupled V-ATPase in vitro
The ability of above described V1 mutants to bind to Vo was tested using BLI. VoND reconstituted with biotinylated MSP was immobilized on streptavidin coated BLI sensors (Fig. 3A, step 1 ) and the VoND coated sensors were then dipped in wells containing V1 mutants and subunit C (Fig. 3A, step 2) . We found that out of the four V1 mutants, only V1Hchim showed significant association with VoND (Fig. 3A, red trace). The BLI signal obtained was attributed to interactions at the V1-Vo interface as the observed on rate (kobs) was significantly (~ 60 fold) reduced in presence of a monoclonal antibody (10D7) against aNT, which is known to only bind free Vo (12) (Supplementary Fig. S2) . The sensors were then dipped in buffer to measure dissociation rates (Fig. 3A, step 3) . However, no significant dissociation was observed, indicating stable assembly of V1Hchim with Vo. Without C, none of the V1 mutants showed significant binding ( Supplementary Fig. S3 ), consistent with studies in yeast that showed that deletion of C prevents assembly of V1Vo (36) . As a control, the sensors were then dipped in prescission protease to cleave and release any remaining complex (Fig. 3A, step 4 ).
While we observed slow, but stable, association of V1Hchim and C with VoND, from the BLI experiment it was not clear whether active and coupled V-ATPase is formed under these conditions. To
Role of subunit H in V-ATPase assembly address this question, we monitored MgATPase activity that is sensitive to the V-ATPase specific inhibitor, Concanamycin A (ConA) of a 1:1:2 mixture of V1Hchim, VoND and C as a function of time (Fig.   3B ). The experiment demonstrated that binding of V1Hchim to VoND in presence of C resulted in the formation of a coupled V1HchimVoND complex, and that the reconstitution under these conditions was complete in ~2 hours, with a final specific activity of 7.2 ± 1.09 U/mg, similar to what is reported for purified wild type V1VoND (6.9 ± 0.6 U/mg) (34) (Fig. 3B , inset, pink and blue bars, respectively). A similar experiment conducted with VoND, C and V1Hwt produced only 0.26 ± 0.2 U/mg of coupled activity (Fig. 3B , inset, orange bar). Therefore, V1Hwt was unable to reconstitute with Vo and C under these experimental conditions, consistent with earlier in vitro studies (33) and the real-time BLI experiments presented here (Fig. 3A) .
Vacuolar lipids are essential for coupled ATPase activity of V1HchimVoND
Lipid moieties, such as long chain sphingolipids (37, 38) , phosphoinositide PI(3,5)P2 (39) , and ergosterol coli polar lipid extract compared to endogenous vacuolar lipids (Fig. 3C) . To test if the lower activity was due to reduced binding of V1Hchim to E. coli lipid containing VoND, we conducted a BLI experiment like the one described in Fig. 3A . Endogenous vacuolar lipid or E. coli polar lipid containing VoND was immobilized on streptavidin sensors using biotinylated MSP. The sensors were then dipped in V1Hchim and C subunit followed by buffer to assess formation and stability of V1HchimVoND (Fig. 3D) . No significant difference was observed in the association or dissociation behavior between the two VoND preparations.
Therefore, while V1Hchim and C was able to bind VoND containing E. coli polar lipids, endogenous vacuolar lipids were essential for the formation of coupled ATPase activity.
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V1HchimVoND is more stable in presence of MgATP compared to V1VoND
Using BLI, we have previously demonstrated that V1's dissociation from Vo is negligible under non-ATP hydrolyzing conditions, but that in presence of MgATP, the complex undergoes spontaneous dissociation at a rate of 1 x 10 -3 ± 3.3 x 10 -6 s -1 (34) . We conducted a similar experiment using V1HchimVoND, wherein after association of V1Hchim and C with VoND on BLI sensors, we dipped the sensors in wells containing buffer or 1 mM MgATP. Unlike V1VoND, V1HchimVoND showed negligible dissociation in the presence of MgATP, suggesting that the assembled V1HchimVoND complex is inherently more stable than V1VoND (Fig. 3E) . The experiment thus highlights the importance of HCT's conformational switch in driving VATPase disassembly.
Structural and functional characterization of V1HchimVoND
To determine the efficiency of V1Hchim VoND complex formation, equimolar amounts of V1Hchim and VoND with a 2-fold excess of C were incubated for up to 16 hours at 22 ºC, and the reconstitution mixture was resolved by glycerol density gradient centrifugation. SDS-PAGE of the gradient fractions showed that the majority of V1 and Vo subunits co-migrated to fractions 7-10, similar to what was observed for purified wild type V1VoND (34) , with the excess C subunit remaining in lighter fractions (Fig. 4A) .
Negative stain EM of the peak fractions showed single particles of V1HchimVoND, with the typical dumbbell shaped appearance of V1Vo observed in multiple studies (26, 28, 34, 41, 42) (Fig. 4B) . A more detailed analysis indicated a good match between averages obtained by reference free alignment and classification of a small dataset of V1HchimVoND and corresponding projections of a cryoEM model of yeast V1Vo (28) (Fig. 4C) .
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Discussion:
The release of HCT from its inhibitory position is necessary and sufficient for in vitro reconstitution of V1 and C with Vo
In our experiments, only V1Hchim shows significant binding to Vo in the presence of C. As mentioned earlier, in V1Hchim, HCT lacks the inhibitory loop (32) (Supplementary Fig. S1A-D, red spheres) , which probably reduces HCT's affinity for V1, in turn diminishing H subunit mediated inhibition of V1's MgATPase activity (Fig. 2B,C) . We therefore conclude that for V1 to reconstitute with Vo, HCT must be released from its inhibitory position on V1, making it available for binding to aNT as part of Vo. Upon disassembly of V1 from Vo, aNT moves from a peripheral position in V1Vo to a more medial position, where it binds subunit d in autoinhibited Vo (Supplementary Fig. S1E-G) . Four separate EM reconstructions of purified yeast Vo show aNT in the medial position bound to d (16, (29) (30) (31) ) and so we conclude that in our preparation of VoND, aNT is in a similar autoinhibitory conformation (Supplementary Fig. S1E-G) . In our reconstitution experiments, V1Hchim, C subunit and autoinhibited VoND are sufficient to form a structurally and functionally coupled V-ATPase, suggesting that no conformational change in aNT is required, and the release of HCT from its autoinhibitory position on V1 is necessary and sufficient for reassembly of V1 and Vo. Our finding is consistent with the fact that reassembly of V1 with Vo on vacuoles is not inhibited by Con A, an inhibitor of c-ring rotation in the Vo sector (14) .
Release of inhibitory MgADP may cause detachment of HCT from its inhibitory position on V1
HNT and HCT occupy specific binding sites on free V1, with HNT bound to EG1 and HCT bound to the bottom of the A3B3 hexamer, with its inhibitory loop wedged between the B subunit of an open catalytic site and the central stalk ( Supplementary Fig. S1A-D) (32) . The specific interaction of HCT with an open catalytic site maintains inhibitory MgADP in the adjacent closed catalytic site, locking autoinhibited V1 in rotational state 2. We have recently observed that transient MgATP hydrolysis on V1Hwt, which, unlike wild type V1, is not in the MgADP inhibited state (Fig. 2B) , lowers H's affinity for V1, and we reasoned Role of subunit H in V-ATPase assembly that this destabilization of the V1-H interaction is caused by MgATP hydrolysis driven conformational changes at the catalytic sites and the central (DF) and peripheral stalks (EG1-3) (24) . We propose that an allosteric structural change at the open catalytic site driven by release of inhibitory MgADP from the closed catalytic site in autoinhibited, wild type V1 (by a yet unknown mechanism) leads to the detachment of HCT from its inhibitory position at the open site, making it in turn available to bind aNT on Vo.
Incorporation of C subunit and the possible role of the RAVE complex
From studies in yeast it was shown that while C is required for binding of V1 to Vo on yeast vacuolar membranes (36) , deletion of H allows assembly of a labile, but inactive, complex (27, 43) . The requirement of C for association of V1 with Vo is supported by our in vitro BLI experiments, wherein none of the V1 mutants reconstituted with Vo in absence of C (Supplementary Fig. S3 ). However, unlike in vivo, the presence of C along with V1ΔH, wild type V1, or V1Hwt is not sufficient for reconstituting V1Vo in vitro. This discrepancy is not due to a reduced affinity of C for V1, as we obtained a Kd of ~0.7 nM for the interaction between C and V1ΔC (Supplementary Fig. S4) . A high-affinity interaction between C and V1ΔC is consistent with sub-stoichiometric amounts of C remaining associated with purified V1ΔH and V1 (32) , as well as the reported Kd of ~42 nM for the EG-C interaction (25) . However, tight binding of C to V1ΔC is inconsistent with the release of C into the cytosol upon disassembly of V1 from Vo in yeast. It has been reported that in the presence of the microtubule depolymerizing drug benomyl, C does not dissociate from V1Vo upon glucose removal (44) . In addition, a direct interaction between C and tubulin has been observed (44, 45) , suggesting the possibility that, upon disassembly, C is sequestered by microtubules, preventing its re-association with V1 and/or Vo.
While incorporation of C upon glucose addition occurs in absence of microtubules (44) , efficient (re)assembly of holo V-ATPase requires a heterotrimeric chaperone complex referred to as regulator of H + -ATPase of vacuolar and endosomal membranes (RAVE). It has been proposed that upon receiving the signal for reassembly, RAVE recruits C and V1 to Vo on vacuolar membranes by directly interacting with C, EG (as part of V1) and aNT (as part of Vo) (46) . Under the in vitro conditions employed here, it takes ~2 hours for a 1:1:2 mixture of V1Hchim, VoND and C to complete reconstitution of V1HchimVoND, a
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relatively slow process compared to the kinetics of reassembly observed in vivo (~5 minutes (47)). It is possible that the RAVE complex, by increasing the proximity of V1, C and Vo, facilitates the otherwise low affinity interactions of the V1-Vo interface, thereby accelerating reassembly.
Proposed model for the reassembly of V1 and C with Vo on the vacuolar membranes of yeast
Based on the here presented data, we conclude that the detachment of HCT from V1 and the presence of C subunit are required for the reassembly of V1 with Vo ( Fig. 5A-C) . In our in vitro reconstitutions, the association between V1Hchim and VoND is driven by the HCT-aNT interaction (Fig. 5B) , but in vivo, the chain of events that leads to reassembly of autoinhibited V1 and Vo are probably different, as HCT is in its inhibitory conformation on V1 (Fig. 5A) . We propose that in yeast, upon receiving cellular signals, autoinhibited V1 and C are first recruited to Vo (Fig. 5D) , a process that is likely the rate limiting step for reassembly. Our reason for this hypothesis is that even with the requirements for reassembly being met in our in vitro reconstitution of V1Hchim and C with Vo, the rate of reassembly was slow. In vivo, recruitment of V1 and C to Vo is facilitated and probably accelerated by the RAVE complex (46), but efficient (re) assembly in vivo requires additional factors such as the glycolytic enzymes aldolase (48) and phosphofructokinase (47) , whose function in the process is currently not known. Once V1 and C are recruited to Vo at the vacuolar membrane, inhibitory MgADP is released upon unclasping of the closed catalytic site by a yet unknown mechanism (Fig. 5E) . The release of inhibitory MgADP allows MgATP hydrolysis to resume, with concomitant conformational changes at the catalytic sites and rotation of the central stalk (DF), structural changes that result in detachment of HCT from V1 (24) (Fig. 5F) . The proximity of aNT to V1-detached HCT facilitates the HCT-aNT interaction, a requirement for coupling of V1 to Vo in the holo-enzyme (27) . The HCT-aNT interaction stabilizes the peripheral conformation of aNT such that the Cfoot-EG2-aNT ternary complex can be formed, thus completing functional (re)assembly (Fig. 5C) .
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Materials and Methods:
Strains: The yeast strain SF838-5Aα deleted for the vma2 gene (B subunit) vma2Δ::Nat was a kind gift from Dr. Patricia Kane, SUNY Upstate Medical University. A plasmid containing the FLAG tag with a KanMX6 marker, pFA6a-6xGly-FLAG-kanMX6 was a gift from Dr. Mark Hochstrasser (49) (Addgene plasmid #20751). The primers, vph1CTFlagFWD:gctgttgctagtgcaagctcttccgcttcaagcGGGGGAGGCGGG GGTGGAA and vph1CTFlagREV: cctggatgtggatttcgattctaacgttaccccaaggcaaatgatggtcactggtgg GAATTCGAGCTCGTTTAAAC were used to amplify the FLAG tag and KanMX marker from pFA6a-6xGly-FLAG-kanMX6. The ~ 1.8 kb product was gel purified and used for homologous recombination to insert the FLAG-KanMX cassette in the C terminus of vph1 in the yeast strain SF838-5Aα vma2Δ::Nat using the same primers as above. Colonies were selected for growth on YPD G418 plates and the insertion of the FLAG tag at the C terminus of vph1 was confirmed by sequencing.
The construction of chimeric H subunit (Hchim) encoding the N terminal domain from S. cerevisiae
(1-352) and the C-terminal domain (349-483) of the human H subunit into the yeast pRS316 vector has been discussed in (32) . From the pRS316 vector, using the primers MalChimF: TTAGCCGGTACCGGGAGCAACGAAGATATTAATGGAC and MalChimR: TTACCAAAG CTTTTAGCTTCGGGCGGCAG, Hchim was amplified. The primers additionally introduced the restriction sites 5' KpnI and 3' HindIII which were used insert the amplicon into a pMal vector. The resultant vector encoded MBP tagged Hchim separated by a Prescission protease cleavage site, as confirmed by sequencing.
Purification of Vo and its reconstitution into endogenous vacuolar lipid:
Vo was purified from yeast vacuoles and reconstituted into endogenous vacuolar lipid containing nanodiscs as described for V1VoND in (34) . The steps are briefly described as follows.
Purification of biotinylated membrane scaffold protein (MSP):
Biotinylated MSP was purified as described in (34) . Briefly, BL21 (DE3) cells were co-transformed with the plasmids pHBPMSP1E3D1
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and pBirAcm (encoding the BirA gene). Cells were grown in rich broth supplemented with 0.1 mM Dbiotin, 34 µg/ml chloramphenicol and 30 µg/ml kanamycin to an OD595 of ~ 0.5 at 37 ºC followed by induction using 0.5 mM IPTG for 3 to 4 hours. Harvested cells were purified as described in (30) . Briefly, cells were lysed by sonicating for 3 x 30 seconds. The lysate was cleared by centrifugation at 13,000 x g and passed over a nickel-nitrilotriacetic acid affinity column. The column was washed with 10 column volumes of the each of the three buffers: 40 mM Tris-HCl, 300 mM NaCl and 1 % Triton X-100 pH 8; 40 mM Tris-HCl, 300 mM NaCl, 50 mM sodium cholate and 5 mM immidazole, pH 8; 40 mM Tris-HCl, 300 mM NaCl and 10 mM immidazole, pH 8. MSP was eluted with a 10 column volume gradient of the elution buffer (40 mM Tris-HCl, 300 mM NaCl and 100 mM immidazole, pH 8). Purified biotinylated MSP was dialyzed into 25 mM Tris, 150 mM NaCl, 0.5 mM EDTA, pH 7.2, concentrated to ~ 5 mg/ml, snap frozen in liquid nitrogen and stored at − 80 o C until use. 
Isolation of yeast vacuoles:
Extraction of Vo and reconstitution into lipid nanodiscs:
Three batches of purified vacuoles (12 liters each) were typically used for one extraction as described in (34) . Briefly, thawed vacuoles were combined, supplemented with protease inhibitors and solubilized using 1.2 mg of n-dodecyl β-D- containing nanodiscs were subjected to anti-FLAG affinity chromatography to purify Vo containing nanodiscs. The eluate from the FLAG column was then subjected to size exclusion chromatography using a Superdex 200 1 x 30 cm column. Peak fractions from gel filtration were combined and concentrated using a Vivaspin 100,000 MWCO concentrator.
Purification of the chimeric H subunit (Hchim): E. coli Rosetta2 (Novagen) cells expressing N-terminal
MBP tagged Hchim were grown to an OD600 ~0.5 (in LB, 0.2% glucose, 50 µg/ml carbenicillin and 34 µg/ ml chloramphenicol) and expression was induced with 0.5 mM IPTG at 30 o C for 4 hours. Protein was purified using amylose affinity chromatography and the MBP tag cleaved with Prescission protease as previously described (25) . The pH of the cleavage product was adjusted to 7 by overnight dialysis in 25 mM sodium phosphate pH 7, 0.5 mM EDTA and 5 mM BME. At pH 7, Hchim has a predicted charge of + 3.5 whereas the predicted charge of MBP is -9 (Protein Calculator v3.4), allowing separation of the two proteins using cation exchange (carboxymethyl, CM) chromatography. The cleaved MBP came off the CM column in the flow through and wash steps, while pure Hchim was eluted in dialysis buffer supplemented with 100 mM NaCl. The preparation was subjected to a final step using a Superdex 200 1.6 x 50 cm size exclusion chromatography column.
Purification of V1 mutants and subunit C:
WT V1 and V1ΔH were purified from vma10Δ::KanMX (34) and vma13Δ::KanMX, vma10Δ::Nat (35) respectively as described in (32) . In both cases, yeast cells were transformed with a pRS315 vector containing N-terminally FLAG tagged vma10 (G subunit) (51). Cells were grown to an OD595 of ~ 4 in synthetic dropout medium without Leucine (SD -Leu) and harvested by centrifugation at 4000 x g for 15 minutes. Cells were lysed by ~ 15 passes through a microfluidizer (Microfluidics M-110L). Unbroken cells were pelleted by centrifugation at 4000 x g for 30 minutes and
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the resultant supernatant was cleared by centrifugation at 13,000 x g for 40 minutes. Cleared lysate was subjected to affinity chromatography using anti-FLAG resin. The eluate from the FLAG column was concentrated and subjected to size exclusion chromatography using a Superdex 200 1.6 x 50 cm column.
Purified V1ΔH was incubated for one hour at 4 o C with a ~ 5 fold molar excess of either Hwt (purified as in (24)) or Hchim to form the V1Hwt and V1Hchim complex respectively. Excess Hwt or Hchim was removed by gel filtration using a Superdex 200 1.6 x 50 cm column. Subunit C was purified as described in (52) .
Purification of Vo from yeast membranes and its reconstitution into E. coli lipid containing nanodiscs:
The purification of Vo from yeast membranes was adapted from (16) . SF838-5Aɑ vma2Δ::Nat with a FLAG tag on the C-terminus of vph1 was grown in YPD pH 5 media to an OD595 of ~ 8 and harvested by centrifugation at 4000 x g for fifteen minutes. Cell pellets were resuspended in lysis buffer (TBSE buffer supplemented with 8 % sucrose, 2 % sorbitol and 2 % glucose) and stored at -80 o C until use. To the thawed cell pellets, protease inhibitors were added to final concentrations of 2 µg/ml for leupeptin and pepstatin, 1 µg/ml chymostatin and 1 mM PMSF. Cells were lysed by bead-beating using an OMNI MACRO ES programmable digital homogenizer at 20,000 rpm with 0.5 mm Zirconia beads (BioSpec).
The chamber was kept in an ice/salt slush to maintain low temperature during lysis. Cell debris and mitochondria were removed by centrifugation at 1200 x g for 10 minutes followed by a centrifugation at 21,000 x g for 20 minutes. Crude membranes were isolated by centrifugation at 370,000 x g for 1 hour using a Ti-70 rotor in a Beckman ultracentrifuge. The pellet was gently resuspended in membrane wash buffer (25 mM Tris, pH 7.2, 0.5 M Sorbitol), homogenized in one stroke and centrifuged again at 370,000
x g for 1 hour. The final membrane pellet obtained was resuspended in membrane wash buffer and stored at -80 ºC until use. Thawed membranes were supplemented with protease inhibitors (2 µg/ml for leupeptin and pepstatin, 1 µg/ml chymostatin and 1 mM PMSF) and solubilized using 1 mg of n-dodecyl β-D-maltopyranoside (DDM) per mg of membrane protein. The suspension was rotated at 4 ºC for 1 hour and the insoluble fraction was pelleted by centrifugation at 180,000 x g for 1 hour. The supernatant was subjected to affinity chromatography using a 3 ml FLAG column. The peak fractions from the FLAG Role of subunit H in V-ATPase assembly column was reconstituted into lipid nanodiscs using a molar ratio of 0.02 Vo: 1 MSP : 25 lipid (30). 1.25 % DDM (w.r.t the final volume of the reconstitution mixture) was added to E. coli polar lipid extract followed by Vo and biotinylated MSP. The reconstitution mixture was rotated at 4 ºC for 1 hour and the detergent was removed using ~ 0.5 g of activated bio-beads for 2 hours. Vo reconstituted in lipid nanodiscs were separated from empty nanodiscs using size exclusion chromatography (Superdex 200 1.6 x 50 cm column).
Biolayer interferometry (BLI):
Interaction of Vo with the purified V1 mutants was screened using BLI, a light interference based technique, similar to surface plasmon resonance. An Octet-RED system with streptavidin coated biosensors (FortéBio, SA biosensors, catalog number 18-5019) were used for the experiments. All BLI experiments were conducted using 25 mM Tris-HCl pH 7.2, 150 mM NaCl, 0.5 mM EDTA, 1 mM BME, 0.5 mg/ml BSA. The temperature was maintained at 22 ºC, with each biosensor stirred in 0.2 ml of sample at 1000 rpm and a standard measurement rate of 5 s -1 . Streptavidin coated biosensors were pre-wetted in BLI buffer and then dipped in wells containing 3 µg/ml of biotinylated VoND. A buffer control was included to show that none of the buffer components interacted with the sensors. Details of individual experiments have been described in the respective figure legends. The affinity of interaction between V1ΔC and MBP-C was measured using anti-mouse IgG Fc capturing biosensors (FortéBio, AMC biosensors catalog number 18-5088) as described (24) .
ATPase activity assay: MgATPase activity of purified V1 mutants and reconstitution mixtures (V1 mutants + VoND + subunit C) was measured using a coupled enzyme assay as described in (32) . Briefly, 10 µg of the V1 mutant was added to an assay mixture containing 1 mM MgCl2, 5 mM ATP, 30 units/ml each of lactate dehydrogenase and pyruvate kinase, 0.5 mM NADH, 2 mM phosphoenol pyruvate, 50 mM HEPES, pH 7.5, at 37 ºC. The decrease of absorbance at 340 nm corresponding to the decline of NADH in the system was measured in the kinetics mode on a Varian Cary Bio100 spectrophotometer. In case of reconstitution mixtures, 20 µg of V1 mutant with equimolar amounts of VoND and a 2X molar excess of C subunit was added to an assay containing 4 mM MgCl2. 
A
VoND was immobilized on streptavidin coated BLI sensors via biotinylated MSP (step 1). Sensors were then dipped into 0.4 µM of V1 mutants in presence of 1 µM C (association; step 2) followed by buffer (dissociation; step 3). Association with VoND was most efficient with V1Hchim (red trace). Sensors were then dipped in prescission protease to verify that the BLI signal was not due to nonspecific binding (step 4). Inset shows an enlarged view of the association and dissociation steps B Equimolar amounts of V1Hchim and VoND, and a twofold molar excess of C subunit were incubated at 22 °C, and the ConA sensitive MgATPase activity was measured as a function of time. Each point represents the mean ± s.e.m. of two separate reconstitutions from two individual purifications. Inset, specific MgATPase activities of reconstituted V1HchimVoND and V1HwtVoND (± s.e.m. from two independent purifications) compared to purified V1VoND (34 A Reconstituted V1HchimVoND was subjected to glycerol gradient centrifugation and the gradient fractions were analyzed by silver stained SDS-PAGE. B
Negative stain EM of V1HchimVoND showing homogeneous and monodisperse dumbbell shaped molecules. C A dataset of ~5800 particle projections was subjected to reference-free alignment and classification, and selected class averages were overlaid with projections of the cryoEM model of yeast V1Vo (28) (pdb id: 3J9U). Bar in (B) = 50 nm. A-C Our in vitro experiments have shown that while wild type H containing V1 does not readily bind VoND (A), V1Hchim spontaneously associates with VoND (B) to form a structurally and functionally coupled V-ATPase, albeit at a slow rate (C). In vivo, however, V1 exists in the autoinhibited conformation (A), and the rate of assembly with Vo is significantly faster (within 5 minutes). D-F For in vivo (re)assembly, we propose that the following steps occur: 1., recruitment of V1 and subunit C to the vacuolar membrane (D); 2., release of inhibitory MgADP (E); 3., detachment of HCT from its inhibitory position on V1 and 4., HCT binding to aNT (F). For further details, see text.
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Figure 4
Role of subunit H in V-ATPase assembly Fig. S2 , Assembly of V1Hchim with Vo is inhibited by an aNT specific monoclonal antibody. A, VoND was immobilized on streptavidin sensors and the sensors were then dipped in either α-aNT mAb (10D7; blue and orange), V1Hchim + C (green) or buffer (pink) (step 2). V1Hchim + C bound to VoND was then dipped in buffer while α-aNT mAb bound to VoND was dipped in V1Hchim + C (blue) or buffer (orange) (step 3). The red buffer trace was subtracted from all other traces and the resultant curves are shown in the inset. The curves obtained for V1Hchim + C's association with VoND in the presence (blue) or absence (green) of bound α-aNT mAb were fit to a single site binding equation (dotted lines). Observed on rates (kobs) were 1.1 x 10 -3 ± 2.7 x 10 -6 without α-aNT mAb (green) and 7.3 x 10 -4 ± 3.4 x 10 -6 with α-aNT mAb (blue). A representative experiment out of two repeats is shown here. B, Schematic showing inhibition of V1Hchim + C's interaction with VoND in presence of α-aNT mAb bound to aNT on Vo. Supplementary Fig. S3 , V1 mutants do not reconstitute with Vo in the absence of subunit C. VoND immobilized on streptavidin sensors was dipped in 0.4 µM V1ΔH (pink), V1Hwt (blue), V1Hchim (purple) and V1Hchim with 1µM C subunit (red) followed by buffer. Compared to V1Hchim + C, none of the V1 mutants showed significant signal for binding to VoND. A representative from two separate experiments is shown. Supplementary Fig. S4 , Binding of the C subunit to V1ΔC as analyzed by BLI. Anti-MBP antibody at 1 µg/ml was immobilized on anti-mouse IgG Fc capture (AMC) sensors. Anti-MBP containing sensors were dipped in 5 µg/ml MBP-C containing wells followed by wells containing 10.5, 21, 42, 84, and 168 nM of V1ΔC and buffer as control. All sensors were then dipped in buffer for dissociation. MBP-C dissociated from anti-MBP at a slow rate which was subtracted for the analysis of kinetic data. The association and dissociation curves were fit to a global single site model, giving a Kd of ~0.7 nM. A representative from two separate experiments is shown.
